Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Acetyl-L-carnitine (ALCAR)

Acetyl-L-Carnitine (ALCAR) · also known as ALCAR, Acetylcarnitine

ALCAR takes part in transporting long-chain fatty acids into mitochondria, and it can supply the acetyl group used to make acetylcholine. These effects have mainly been seen in animal and in-vitro studies. The effects of standard oral doses in human mitochondria and brain have not been confirmed.

Typical dose: 500–1500 mg/day, taken on an empty stomach in the morning or before a period of heavy mental work.
Absorption and forms: ALCAR enters the bloodstream after oral dosing. A pharmacokinetic study in 8 healthy people showed that plasma ALCAR rose after 500 mg by mouth. Several common claims lack adequate human evidence: that ALCAR crosses into the brain better than plain L-carnitine, that it is absorbed better on an empty stomach, and that it should be kept away from protein meals rich in branched-chain amino acids because they compete for absorption. Human data on brain tissue exposure after oral dosing are also limited.

Clinical uses and human evidence

Low mood

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Veronese 2018 · Psychosom Med · Meta-analysis · n=791 — Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis

Age-related cognitive decline

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Montgomery 2003 · Int Clin Psychopharmacol · Meta-analysis · n=1204 — Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
  2. Hudson 2003 · Cochrane Database Syst Rev · Systematic review — Acetyl-L-carnitine for dementia

Peripheral neuropathy (numbness and tingling)

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Rolim 2019 · Cochrane Database Syst Rev · Meta-analysis · n=907 — Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy
  2. Hershman 2013 · J Clin Oncol · RCT · n=409 — Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

Fatigue and energy

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Tomassini 2004 · J Neurol Sci · Randomized crossover trial · n=36 — Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial
  2. Hershman 2013 · J Clin Oncol · RCT · n=409 — Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy

Male fertility (sperm quality)

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Lenzi 2004 · Fertil Steril · RCT · n=60 — A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia

Mechanisms of action

Acylcarnitine shuttle into mitochondria and β-oxidation

★★★☆☆Mechanism evidence: grade C

After ALCAR is taken, it can be converted to free carnitine, which serves as the shuttle substrate that carries long-chain acyl groups into mitochondria. In rats, high-dose ALCAR improved CPT1 activity in the heart of aged animals. However, whether the carnitine pool and fatty acid oxidation in human muscle change after standard oral doses is still uncertain.

References (2)
  1. Gómez 2012 · Rat study: high-dose ALCAR improved CPT1 activity in the heart of aged rats
  2. 2004 · Pharmacokinetic study in 8 healthy people: plasma ALCAR rose after 500 mg by mouth, and muscle CPT flux was not measured

Cholinergic neurotransmission (ACh precursor supply and AChE inhibition)

★★★☆☆Mechanism evidence: grade C

The acetyl group carried by ALCAR is first transferred to coenzyme A and then used to make acetylcholine. ALCAR itself does not supply choline. Studies in isolated nerve tissue and in rat brain microdialysis showed that it increases acetylcholine release in some brain regions. However, the effect of standard oral doses on synaptic acetylcholine in humans is unclear.

References (2)
  1. White and Scates 1990 · In-vitro rat nerve tissue experiment: the acetyl group from ALCAR reached acetylcholine through coenzyme A
  2. 1989 · Rat brain microdialysis study: ALCAR increased acetylcholine release in some brain regions

PGC-1α-driven mitochondrial biogenesis and proliferation

★★☆☆☆Mechanism evidence: grade CSecondary target

After ALCAR feeding, transcription of PGC-1α, NRF-1 and TFAM rose in the disused muscle of rats, which suggests it may take part in mitochondrial biogenesis. The result comes from an animal model, and no reliable human study shows that standard doses increase mitochondrial number through PGC-1α.

References (1)
  1. Cassano 2006 · Rat study: after ALCAR feeding, transcription of PGC-1α, NRF-1 and TFAM rose in disused muscle

Safety and drug interactions

Use with caution in people with uncontrolled hypothyroidism, because carnitine may inhibit peripheral uptake of thyroid hormone. Taking it in the evening may affect how quickly you fall asleep. Carnitine may be linked to TMAO, a metabolite produced by gut bacteria. Its long-term clinical significance is still uncertain, and it should not be treated as a confirmed cardiovascular risk.
Open in the interactive app ›